Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who are able to give informed consent to participate
- People with a performance status rating of 0–2 on the ECOG scale, meaning they are fully active or able to carry out light activity (confirm with trial site)
- People whose cancer has been confirmed by tissue testing as squamous cell carcinoma (a specific type of cancer cell)
- People whose tumor has tested positive for a protein called p16, as measured by a laboratory test at their local hospital
- People whose cancer started in the oropharynx — the middle part of the throat, including the tonsils, soft palate, base of the tongue, or the walls of the throat
- People whose treatment plan is aimed at curing the cancer
- Both smokers and non-smokers are included
- People whose tumor is classified as stage T1, T2, or T3 under standard cancer staging guidelines (AJCC 8th edition)
- People whose lymph node involvement is classified as N1 or N2 under standard cancer staging guidelines (AJCC 8th edition)
- People whose blood counts, liver function, and kidney function meet the levels required to safely receive chemotherapy (confirm specific values with trial site)
Who may not be able to join:
- People who have cancer involvement in a specific group of lymph nodes in the neck known as level Ib nodes, including spread into the submandibular gland (a saliva gland under the jaw)
- People whose cancer has spread into the mouth (oral cavity)
- People whose cancer has spread to other parts of the body (metastatic disease)
- People who have medical reasons that prevent them from receiving radiation therapy or chemotherapy
- People who have had a head or neck cancer within the past 5 years
- People who have previously received radiation treatment to the head or neck at any time
- People who are unable to complete the full course of radiation treatment or attend all required follow-up appointments
- People who are pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Harvey Quon, MD, Tom Baker Cancer Centre
Phone: 403-521-3619
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Xerostomia-related quality of life; Toxicity Criteria for Adverse Events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.